PortfoliosLab logoPortfoliosLab logo
SPRY vs. STZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SPRY vs. STZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Silverback Therapeutics Inc (SPRY) and Constellation Brands, Inc. (STZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SPRY achieves a -11.76% return, which is significantly lower than STZ's 5.30% return.


SPRY

1D
3.01%
1M
29.47%
YTD
-11.76%
6M
-6.80%
1Y
-37.96%
3Y*
17.85%
5Y*
-20.88%
10Y*

STZ

1D
1.32%
1M
-4.09%
YTD
5.30%
6M
4.34%
1Y
-9.82%
3Y*
-14.32%
5Y*
-7.06%
10Y*
0.95%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SPRY vs. STZ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
SPRY
Silverback Therapeutics Inc
-11.76%10.43%92.52%-35.76%28.08%-85.63%59.79%
STZ
Constellation Brands, Inc.
5.30%-35.99%-7.11%5.83%-6.43%16.12%4.42%

Correlation

The correlation between SPRY and STZ is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Dec 4, 2020

0.10

Fundamentals

Market Cap

SPRY:

$1.02B

STZ:

$24.90B

EPS

SPRY:

-$2.00

STZ:

$11.23

PS Ratio

SPRY:

10.26

STZ:

2.74

PB Ratio

SPRY:

16.65

STZ:

2.97

Total Revenue (TTM)

SPRY:

$98.99M

STZ:

$9.14B

Gross Profit (TTM)

SPRY:

$59.93M

STZ:

$4.71B

EBITDA (TTM)

SPRY:

-$194.60M

STZ:

$3.05B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SPRY vs. STZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SPRY
SPRY Risk / Return Rank: 2121
Overall Rank
SPRY Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
SPRY Sortino Ratio Rank: 1919
Sortino Ratio Rank
SPRY Omega Ratio Rank: 2020
Omega Ratio Rank
SPRY Calmar Ratio Rank: 2121
Calmar Ratio Rank
SPRY Martin Ratio Rank: 2626
Martin Ratio Rank

STZ
STZ Risk / Return Rank: 2828
Overall Rank
STZ Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
STZ Sortino Ratio Rank: 2525
Sortino Ratio Rank
STZ Omega Ratio Rank: 2626
Omega Ratio Rank
STZ Calmar Ratio Rank: 3131
Calmar Ratio Rank
STZ Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SPRY vs. STZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Silverback Therapeutics Inc (SPRY) and Constellation Brands, Inc. (STZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SPRYSTZDifference
Sharpe ratioReturn per unit of total volatility

-0.25

Sortino ratioReturn per unit of downside risk

-0.30

Omega ratioGain probability vs. loss probability

0.94

0.97

-0.03

Calmar ratioReturn relative to maximum drawdown

-0.60

-0.37

-0.23

Martin ratioReturn relative to average drawdown

-0.85

-0.65

-0.21

SPRY vs. STZ - Sharpe Ratio Comparison

The current SPRY Sharpe Ratio is -0.58, which is lower than the STZ Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of SPRY and STZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SPRY vs. STZ - Drawdown Comparison

The maximum SPRY drawdown since its inception was -95.20%, which is greater than STZ's maximum drawdown of -67.39%. Use the drawdown chart below to compare losses from any high point for SPRY and STZ.


Loading charts...

Drawdown Indicators


SPRYSTZDifference

Max Drawdown

Largest peak-to-trough decline

-95.20%

-67.39%

-27.81%

Max Drawdown (1Y)

Largest decline over 1 year

-63.32%

-26.51%

-36.81%

Max Drawdown (3Y)

Largest decline over 3 years

-63.32%

-51.28%

-12.04%

Max Drawdown (5Y)

Largest decline over 5 years

-91.77%

-51.28%

-40.49%

Max Drawdown (10Y)

Largest decline over 10 years

-53.53%

Current Drawdown

Current decline from peak

-82.98%

-44.56%

-38.42%

Average Drawdown

Average peak-to-trough decline

-78.26%

-16.62%

-61.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

44.52%

15.21%

+29.31%

Volatility

SPRY vs. STZ - Volatility Comparison

Silverback Therapeutics Inc (SPRY) has a higher volatility of 18.34% compared to Constellation Brands, Inc. (STZ) at 8.56%. This indicates that SPRY's price experiences larger fluctuations and is considered to be riskier than STZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SPRYSTZDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.34%

8.56%

+9.78%

Volatility (6M)

Calculated over the trailing 6-month period

45.49%

23.48%

+22.01%

Volatility (1Y)

Calculated over the trailing 1-year period

66.37%

30.33%

+36.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.08%

24.58%

+55.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.79%

26.99%

+53.80%

Dividends

SPRY vs. STZ - Dividend Comparison

SPRY has not paid dividends to shareholders, while STZ's dividend yield for the trailing twelve months is around 2.85%.


PositionTTM20252024202320222021202020192018201720162015
SPRY
Silverback Therapeutics Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
STZ
Constellation Brands, Inc.
2.85%2.95%1.77%1.44%1.36%1.21%1.37%1.58%1.70%0.86%0.98%0.65%

Financials

SPRY vs. STZ - Financials Comparison

This section allows you to compare key financial metrics between Silverback Therapeutics Inc and Constellation Brands, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B3.00B20222023202420252026
22.68M
1.92B
(SPRY) Total Revenue
(STZ) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SPRY and STZ have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SPRY has higher volatility (18.34%) compared to STZ (8.56%). In terms of maximum drawdown, SPRY dropped -95.20% vs STZ's -67.39%.

STZ currently has the higher Sharpe Ratio (-0.32 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SPRY and STZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer